Pulmonx Corporation Profit Margin 2019-2024 | LUNG
Current and historical gross margin, operating margin and net profit margin for Pulmonx Corporation (LUNG) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pulmonx Corporation net profit margin as of September 30, 2024 is -67.31%.
| Pulmonx Corporation Annual Profit Margins |
|---|
| Pulmonx Corporation Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||